GO TO
- How to Join
- Renew Membership
- News
- Events
- Publications
- Presentations
- Sponsors
- Corporate Members
- Links
SPONSORS
David S. Young
Dr. Young oversees general corporate strategy and directs the Company’s scientific program. He received his Doctor of Medicine degree in 1990 and Master of Science degree through the Surgical Scientist Program in 1996, both from the University of Toronto. He did his surgical training at the University of Toronto between 1991 and 1997. While at U of T he won over 15 academic awards or scholarships. He is an inventor, author, or co-author of over 200 patents, publications, and scientific abstracts. He began his research career studying the role of the immune system in xenograft rejection in cardiac transplantation and has moved forward investigating its role in cancer. Dr. Young established ARIUS to commercially develop antibodies that can be manipulated to fight disease more effectively.
ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further
information, visit www.ariusmabs.com
